Drugs Registration Rules, 2038 (1981)

1. Short title and commencement: (1) These Rules may be called as “Drugs Registration Rules, 2038 (1981)." (2) These Rules shall come into force in such area and on such date as Government of Nepal may appoint by a Notification in the Nepal Gazette.

2. Definitions: Unless the subject or the context otherwise requires, in these Rules,- (a) “Act” means the Drugs Act, 2035(1978). (b) “Department” means the Department of Drugs Administration.

3. Recommendation letter to be obtained to establish drug industry: (1) If a person intends to obtain a recommendation letter to establish a drug industry pursuant to Section 7 of the Act, such person shall make an application to the Department in the format as referred to in Schedule-1. (2) If, on making necessary inquiry into the application after it is made pursuant to Sub-rule (1), the Department thinks it reasonable to issue a recommendation letter to establish that drug industry, it shall issue the recommendation letter to the applicant in the format as referred to in Schedule-2 by
collecting the fees as prescribed in Schedule-14.
Inserted by the First Amendment. 1 www.lawcommission.gov.np www.lawcommission.gov.np

4. Product license to be obtained to manufacture drug : (1) A person who has already established a drug industry after having obtained the recommendation letter pursuant to Sub-rule (2) of rule (3) or a person who has already established a drug industry prior to the commencement of this Act shall make an application to the Department in the format as referred to in Schedule-3 to obtain the product license to manufacture the drug pursuant to section 8 of the Act. (2) After an application is made pursuant to Sub-rule (1), the Department shall make necessary inquiry into the matter and register such drug in the registration book in the format as referred to in Schedule-4 and issue the production license to the applicant in the format as referred to in Schedule-5
by collecting the fees as prescribed in Schedule-14.

4A. Registration of drug prior to its sale and distribution: (1) For purpose of Sub- section (1) of Section 8A. of the Act, an industry having obtained the production license shall, prior to the sale and distribution of each drug manufactured by it, make an application to the Department setting out the following details, in the format as referred to in Schedule-4A., for the registration of the sale and distribution of such drug: (a) Product specification of the manufactured drug, (b) Method of analysis of the manufactured drug and test report conducted by a laboratory specified by the Department, (c) A sample of the manufactured drug, along with the label indicating its price, (d) Other matters specified by the Department. (2) If, upon making necessary inquiry into the application received pursuant to Sub-rule (1), the Department deems proper to sell and distribute the drug mentioned in the application, it shall register such drug and issue the drug sale and distribution registration certificate in the format as referred to in Schedule-4B, by
Amendment by the First Amendment.
Inserted by the First Amendment. 2 www.lawcommission.gov.np www.lawcommission.gov.np collecting the drug registration fees as prescribed in Schedule-14 for each drug. (3) Each drug manufacturer who has obtained the product license pursuant to Section 8 of the Act prior to the commencement of these Rules shall register each drug manufactured by it pursuant to these Rule within one year after the date of commencement of these Rules and obtain the drug sale and distribution registration certificate.

4B. Registration prior to importation of drug: (1) For purposes of Sub-section (2) of Section 8A of the Act, a person who intends to import a drug shall make an application to the Department, setting out the following details of the drug which he intends to import, in the format as referred to in Schedule-4C, for the drug import registration certificate: (a) A certified copy of the certificate issued by an authentic body certifying that the manufacturer has followed good manufacturing practices, (b) Product specification of the manufactured drug, (c) Method of analysis of the manufactured drug and test report conducted by a laboratory specified by the Department, (c) Pharmacopoeia standard, (d) A sample of the manufactured drug, (e) Other matters specified by the Department. (2) Notwithstanding anything contained in Sub-rule (1), in making an application to import any Ayurvedic, homeopathic and other traditional drug, the following details shall be attached with it: (a) Details mentioned in the book or literature, (b) Product specification of the manufactured drug, (c) Recommendation of the concerned body in the case of a patented drug, (d) A sample of the manufactured drug, and 3 www.lawcommission.gov.np www.lawcommission.gov.np (e) Other matters specified by the Department. (3) If, on making necessary inquiry into the application received pursuant to Sub-rule (1), the Department deems proper to import the drug mentioned in the application, it shall register such drug in the format as referred to in Schedule-4D and issue the certificate in the format as referred to in Schedule-4E by collecting the drug registration fees as prescribed in Schedule-14 for each drug. (4) Notwithstanding anything contained in Sub-rules (1) and (2), the Department may, on recommendation of the drug advisory committee, issue the import recommendation letter for importing the following drug in the following circumstance: (a) In the case of a life saving drug, on the basis of the concerned doctor, (b) Where a drug is imported as a grant to a governmental or nongovernmental body or organization, (c) Where a governmental body imports a drug as per the international bidding system.

5. Recommendation letter to be obtained for exportation or importation of drug: (1) For purposes of Section 9 of the Act, a person who intends to import or export a drug shall make an application to the Department in the format as referred to in Schedule-6. (2) If, on making necessary inquiry into the application received pursuant to Sub-rule (1), the Department deems proper to import or export the drug mentioned in the application, it shall issue the recommendation letter in the format as referred to in Schedule-7 by collecting the drug import and export fees as prescribed in Schedule-14.

6. To obtain certificate of registration of name, and shop or firm selling and distributing drug: (1) If a person intends to obtain a certificate after having his
Amendment by the First Amendment. 4 www.lawcommission.gov.np www.lawcommission.gov.np name and shop or firm pursuant to Section 10 of the Act, such person shall make an application to the Department in the format as referred to in Schedule-8. (2) If, on making necessary inquiry into the application after it is made pursuant to Sub-rule (1), the Department thinks it reasonable to issue such certificate, it shall register the name of the person and shop or firm selling and distributing the drug in the registration book in the format specified by it and issue the certificate to the applicant in the format as referred to in Schedule-9, by collecting the fees as
prescribed in Schedule-14.

7. To obtain license to make publicity or advertisement of drug: (1) If a person intends to obtain a license to make publicity or advertisement of a drug pursuant to Sub-section (2) of Section 19 of the Act, such person shall make an application to the Department in the format as referred to in Schedule-10. (2) If, on making necessary inquiry into the application after it is made pursuant to Sub-rule (1), the Department deems proper to publicize or advertise the drug mentioned in the application, it shall issue the drug publicity or advertisement license in the format as referred to in Schedule-11 by collecting the drug publicity or advertisement fees as prescribed in Schedule-14 for each drug to be publicized or advertised, subject to section 19 of the Act.

8. License to be obtained for clinical trial of new drug: (1) If a person intends to carry out a clinical trial of any new drug pursuant to Section 31 of the Act, such person shall make an application to the Department in the format as referred to in Schedule-12. (2) If, upon making necessary inquiry into the application after it is made pursuant to Sub-rule (1), the Department deems proper to issue the license to carry out the clinical trial of that new drug, it shall issue the license in the format as referred to in Schedule-13, by collecting the
fees as prescribed in Schedule-14.

9. Renewal fees: The renewal fees as referred to in Schedule-14 shall be chargeable
Inserted by the First Amendment.
Inserted by the First Amendment. 5 www.lawcommission.gov.np www.lawcommission.gov.np for the renewal, pursuant to Sub-section (2) of section 11 of the Act, of any license, certificate and recommendation letter issued pursuant to these Rules.

10. Issuance of duplicate copy: (1) If any recommendation letter, product license, license or certificate issued pursuant to these Rules is lost or otherwise destroyed, the concerned person who intends to obtain a duplicate copy thereof shall make an application, with a stamp of one rupee being affixed thereto, and setting out the details of such loss or destroy, to the Department. (2) After an application as referred to in Sub-rule (1) is made, the Department may issue a certified duplicate copy of such recommendation letter, product license, license or certificate to the applicant,
by collecting the fees as referred to in Schedule-14.

11. Observance of codes: A person who has obtained a recommendation letter, product license, license and certificate pursuant to these Rules shall, while doing, or causing to be done, any act as referred to in such recommendation letter, product license, license or certificate, observe the codes issued by the Department in respect of such act.

12. Power of Government of Nepal to alter the Schedule: Government of Nepal may, by a Notification published in the Nepal Gazette, make necessary alteration on the Schedules. 6 www.lawcommission.gov.np www.lawcommission.gov.np Schedule-1 (Relating to Sub-rule (1) of Rule 3) Application for recommendation letter of establishment of drug industry The Administrator, Department of Drugs Administration. Subject: Request for recommendation letter for establishment of drug industry. Sir, Whereas, I/we intend to establish the following drug industry; Now, therefore, I/we make this application, affixing a stamp of one rupee hereto, and setting out the following details, to obtain a recommendation letter for the same.

1. Proposed drug industry's: (a) Name: (b) Place where it is established: (Also mention the name and ward number of the District and Municipality or Village Development Committee) (c) Estimated capital and source of that capital: (d) Where a preliminary study report carried out on the establishment is attached or not: (e) Whether a sketch and map of the plan also showing the area where the industry is to be established is attached or not: S.N. Of the drug to be manufactured by the proposed Remarks Name System (et out whether it is Group or Composition (set out Allopathic , Homeopathic, sub-group whether it is a tablet, Ayurvedic, Unani etc. injection, capsule etc.) 7 www.lawcommission.gov.np www.lawcommission.gov.np

2. For the manufacturing of drug by proposed industry: (a) Description of required raw materials and source thereof: (b) Whether a machine is required or not, if so required, possible details thereof: (c) Of the required house or building: (1) Whether sketch and map is attached or not: (2) What will be its composition: (3) Whether outside environment will be polluted, neat and clean or otherwise, mention it: (4) Whether the air can pass through the room or not: Mention why and for what reasons such room has to be so built that the air can or cannot so pass through it: (5) Whether the sun or light can enter the room or not: Mention why and for what reasons such room has to be so built that the sun or light can or cannot so enter it: Applicant's: Signature: Name, surname: Address: Date: 8 www.lawcommission.gov.np www.lawcommission.gov.np Schedule-2 (Relating to Sub-rule (2) of Rule 3) Government of Nepal Ministry of Health Department of Drugs Administration Recommendation letter for establishment of drug industry This recommendation letter is hereby issued, setting out the following matters, for the establishment of the following drug industry, subject to the Drugs Act, 2035 (1978) and the Drugs Registration Rules, 2038 (1981).

1. Of the drug industry recommended for establishment: (a) Name: (b) Place where it is established: (c) Estimated capital:

2. Of the drug that can be manufactured by the drug industry after having obtained the product license: Of the drug Remarks Name System Group of sub-group Composition

3. Recommendation letter receiving person's: (a) Name and surname: (b) Address:

4. Validity period of recommendation letter: Signature of the recommendation letter receiving person: 9 www.lawcommission.gov.np www.lawcommission.gov.np Date: Recommendation letter issuing officer's: Signature: Name and surname: Designation: Date: (The matters to be written on the back side of this recommendation letter) Renewal of the recommendation letter Recommendation letter Validity extension period Renewing Renewal fees Department's Remarks From To Officer's Seal signature and date 10 www.lawcommission.gov.np www.lawcommission.gov.np Schedule-3 (Relating to Sub-rule (1) of Rule 4) Application for product license The Administrator, Department of Drugs Administration. Sir, Whereas, in order to manufacture the following drugs by the following drug industry already established after having obtained the following recommendation letter and license, I/we intend to obtain the product license by having the drugs registered; Now, therefore, I/we have made this application, affixing a stamp of one rupee hereto, to obtain the product license. The duplicate copies of the recommendation letter and license are attached herewith.

1. Serial number of the recommendation letter of that Department and date thereof: 2. Date of license obtained from-----Department:

3. Drug industry: (a) Name: (b) Place of establishment: (Also mention the name and ward number of the district, Municipality and Village Development Committee.) Drug to be manufactured S.N. Name System Group Composition Type Colour Weight Active ingredient Disease to be or of per Name Quantity cured from sub- kind unit consumption group

5. Whether the required materials related with the manufacture of drugs are available in an adequate quantity or not: Applicant's: Signature: Name and surname: Address: Date: 11 www.lawcommission.gov.np www.lawcommission.gov.np Schedule-4 (Relating to Sub-rule (2) of Rule 4-----) Registration book The following drug has been registered as follows for its manufacture,
subject to the Drugs Act, 2035(1978) and the Drugs Registration Regulation, 2038(1981). Registration Of the drug No Name System Group Composition Type Colour Active ingredient Disease to Name Registering or or be cured manufacturing officer's sub- kind from its company and signature group consumption country and date Name Quantity  Deleted by the First Amendment.
Inserted by the First Amendment. 12 www.lawcommission.gov.np www.lawcommission.gov.np Schedule-4A
(Relating to Sub-rule (1) of Rule 4) Application for drug sale and distribution registration certificate The Administrator, Department of Drugs Administration. Dear sir, Whereas, the drug as referred to in the product license, bearing number..........., issued by that Department is appropriate for sale and distribution; Now, therefore, I/we have made this application, setting out the following details and affixing a stamp of five rupees hereto, to obtain the sale registration certificate, pursuant to Sub-rule (2) of Rule 4A. of the Drugs Registration Rules, 2038(1981).

1. Drug of which sale registration certificate is intended to be obtained: (a) Name: (b) System: (c) Group or sub-group: (d) Composition: (e) Active ingredient and quantity (per unit): (f) Expiry date: (g) Pharmacopoeia standard: (h) Retail price: (i) Laboratory having conducted analysis and test, and the analysis and test report issued by that laboratory and date thereof:
Inserted by the First Amendment. 13 www.lawcommission.gov.np www.lawcommission.gov.np

2. Other details: (a) Whether the product specification setting down the size, color, measurement or weight, taste and flavor of drug, method of packing and details mentioned in its label is attached or not: (b) Whether the method of analyzing and testing the drug is attached or not: (c) Whether the label, cartoon and sample of drug is attached or not: Applicant's: Signature: Name and surname: Address: Date: 14 www.lawcommission.gov.np www.lawcommission.gov.np Schedule-4B
(Relating to Sub-rule (2) of Rule 4A.) Government of Nepal Ministry of Health Department of Drugs Administration Drug sale and distribution registration certificate Sale and distribution registration certificate number: Sir, The sale and distribution registration certificate has been issued for the following drug, pursuant to Sub-section (1) of section 8A of the Drugs Act, 2035(1978) and Sub-rule (2) of Rule 4A of the Drugs Registration Rules, 2038 (1981). 1. Of the drug: (a) Name: (b) System: (c) Group and sub-group: (d) Composition: (e) Active ingredient and quantity (per unit): (f) Expiry date:

2. Product specification (certified copy is attached):

3. Fees received for the sale registration certificate: Rs.---

4. Validity period of certificate: Certificate receiver's: Name and surname: Address: Signature: Date: Certificate issuing officer's: Signature: Name and surname: Designation: Date:
Inserted by the First Amendment. 15 www.lawcommission.gov.np www.lawcommission.gov.np Note bene: Prior approval has to be obtained from the Department if any alteration is to be made in the product specification and label submitted to the department and in the above- mentioned details: Amendment to the certificate Date Details o Amendment Renewal Period of extension of validity Fees Officer's signature Remarks From To 16 www.lawcommission.gov.np www.lawcommission.gov.np Schedule-4C
(Relating to Sub-rule (1) of Rule 4B) Application for drug import registration certificate The Administrator, Department of Drugs Administration. Sir, I/we have made this application, setting out the following details and affixing a stamp of five rupees hereto, to obtain the drug import registration certificate, pursuant to Sub-section (2) of Section 8A. of the Drugs Act, 2035(1978) and Sub- rule (1) of Rule 4B of the Drugs Registration Rules, 2038 (1981).

1. Drug of which import registration certificate is intended to be obtained: (a) Name: (b) System: (c) Group and sub-group: (d) Composition: (e) Active ingredient and quantity (per unit): (f) Expiry date: (g) Pharmacopoeia standard: (h) Retail price: (i) Laboratory having conducted analysis and test, and the analysis and test report issued by that laboratory and date thereof:
Inserted by the First Amendment. 17 www.lawcommission.gov.np www.lawcommission.gov.np

2. Other details: (a) Whether the product specification setting down the size, color, measurement or weight, taste and flavor of drug, method of packing and details mentioned in its label is attached or not: (b) Whether the method of analyzing and testing the drug is attached or not: (c) Whether the label, cartoon and sample of drug are attached or not: Applicant's: Signature: Name and surname: Address: Date: 18 www.lawcommission.gov.np www.lawcommission.gov.np Schedule-4D
(Relating to Sub-rule (3) of Rule 4B) Registration book The following drug has been registered as follows for its import, subject to the Drugs Act, 2035(1978) and the Drugs Registration Rules, 2038(1981). Of the drug Registering Group Disease to Name Registration Type Active ingredient officer's or be cured manufacturing No Name System Composition or Colour signature Remarks sub- from its company and kind and date group Name Quantity consumption country
Inserted by the First Amendment. 19 www.lawcommission.gov.np www.lawcommission.gov.np Schedule-4E
(Relating to Sub-rule (3) of Rule 4B) Government of Nepal Ministry of Health Department of Drugs Administration Drug import registration certificate Import registration certificate number: Sir, The drug import registration certificate has bee issued, setting out the following details, pursuant to Sub-section (2) of Section 8A of the Drugs Act, 2035(1978) and Sub-rule (3) of Rule 4B. of the Drugs Registration Rules, 2038(1981).

1. Of the drug: (a) Name: (b) System: (c) Group and sub-group: (d) Composition: (e) Active ingredient and quantity (per unit): (f) Expiry date:

2. Manufacturer's: (a) Name: (b) Address and country:

3. Fees received for the import registration certificate: Rs.---

4. Validity period of certificate: Import registration certificate obtainer's: Name and surname: 20 www.lawcommission.gov.np www.lawcommission.gov.np Address: Import registration certificate receiver's: Signature: Name and surname: Address: Date: Certificate issuing officer's: Signature: Name and surname: Designation: Date: Note bene: Prior approval has to be obtained from the Department if any alteration is to be made in the product specification and label submitted to the department and in the above- mentioned details: Amendment to the certificate Date Details of Amendment Renewal Period of extension of validity Fees Officer's signature Remarks From To
Inserted by the First Amendment. 21 www.lawcommission.gov.np www.lawcommission.gov.np Schedule-5 (Relating to Sub-rules (2) and (3) of Rule 4) Government of Nepal Ministry of Health Department of Drugs Administration Serial number: Product license This product license is hereby issued setting out the following matters, allowing the------- -industry already established in -------, based on the following recommendation letter and the license, subject to the Drugs Act, 2035(1978) and the Drugs Registration Rules, 2038(1981).

1. Serial number of the recommendation letter of this Department and date thereof:

2. Date of license obtained from-----Department:

3. Drug industry: (a) Name: (b) Place of establishment: (Also mention the name and ward number of the district, Municipality and Village Development Committee.) Drug licensed for Manufacture Group Active ingredient S.N. Type Weight and Remarks Registration or Name Quantity System Composition or Colour measurement No sub- kind per unit group 22 www.lawcommission.gov.np www.lawcommission.gov.np

4. Product license obtainer's: (a) Name and surname: (b) Address:

5. Fees received for the issuance of product license: Rs.---

6. Validity period of product license: Product license receiver's: Signature: Date: Product license issuing officer's: Signature: Name and surname: Designation: Date: (The matters to be written on the reverse side of this product license) Renewal of the product license Products license Validity extension Department's Renewing officer's Renewal Remarks period Seal signature and date fees From To 23 www.lawcommission.gov.np www.lawcommission.gov.np Schedule-6 (Relating to Sub-rule (1) of Rule 5) Application for drug export/import recommendation letter The Administrator, Department of Drugs Administration. Sir, Whereas, I/we intend to obtain a recommendation letter to export/import the following drug; Now, therefore, I/we have made this application, setting out the following matters and affixing a stamp of one rupee hereto, to obtain the recommendation letter. Drug to be exported/imported Group Active ingredient's Name of or manufacturing S.N. Name System Standard Composition sub- Name Quantity company and group country Applicant's: Signature: Name and surname: Address: Date: 24 www.lawcommission.gov.np www.lawcommission.gov.np Schedule-7 (Relating to Sub-rule (2) of rule 5) Government of Nepal Ministry of Health Department of Drugs Administration Drug export/import recommendation letter This recommendation letter is hereby issued, setting out the following matters, to export/import the following drug, subject to the Drugs Act, 2035(1978) and the Drugs Registration Rules, 2038 (1981). 1. Drug recommended to be exported/imported Group Active ingredient's Name of or manufacturing S.N. Name System Standard Composition sub- Name Quantity company and group country

2. Recommendation letter obtainer's: (a) Name and surname: (b) Address:

3. Validity period of recommendation letter:

4. Recommendation letter receiver's: Signature: Date: 25 www.lawcommission.gov.np www.lawcommission.gov.np Recommendation letter issuing officer's: Signature: Name and surname: Designation: Date: (The matters to be written on the reverse side of this recommendation letter.) Renewal of the recommendation letter Recommendation letter Validity extension Department's Renewing officer's Renewal Remarks period Seal signature and date fees From To 26 www.lawcommission.gov.np www.lawcommission.gov.np Schedule-8 (Relating to Sub-rule (1) of Rule 6) Application for certificate The Administrator, Department of Drugs Administration. Sir, Whereas, I/we intend to have registered my/our name and the name of the following shop or firm and obtain a certificate for the sale and distribution of the following drug; Now, therefore, I/we have made this application, setting out the following matters and affixing a stamp of one rupee hereto, to obtain the certificate.

1. The drug selling and distributing pharmacist or entrepreneur and other person’s: Name and Address Qualifications Whether certified copy Remarks Surname of qualification is Qualification Experiences attached or not

2. Of the shop or firm selling and distributing the drug: (a) Name and address: (b) Estimated capital: (c) Name, surname and address of the owner: 27 www.lawcommission.gov.np www.lawcommission.gov.np 3. Of the drug to be sold and distributed Group Manufacturing Storage SN Remarks System or sub- Composition company and group country Method Means

4. Mode of sale and distribution of the drug: retail/wholesale

5. Whether a certified copy of the document issued by the manufacturer of the drug to be sold and distributed, guaranteeing that such drug is safe for the people, efficacious and of quality standard, is attached or not. If it is not attached, mention that by when it can be submitted. Applicant's: Signature: Name and surname: Address: Date: 28 www.lawcommission.gov.np www.lawcommission.gov.np Schedule-9 (Relating to Sub-Rule (2) of Rule 6) Government of Nepal Ministry of Health Department of Drugs Administration Serial number: Certificate

1. This certificate is hereby issued, setting out the following matters, allowing the following person, shop or firm to sell and distribute the following drug, subject to the Drugs Act, 2035 (1978) and the Drugs Registration Rules, 2038 (1981). Of the pharmacist or entrepreneur and other person allowed to sell and distribute the drug: Qualification Whether certified Name and copy of Address Remarks Surname Qualifications Experiences qualification is attached or not

2. Of the shop or firm allowed to sell and distribute the drug: (a) Name and address: (b) Estimated capital: (c) Name, surname and address of the owner: 29 www.lawcommission.gov.np www.lawcommission.gov.np 3. Of the drug allowed to be sold and distributed Group Manufacturing Storage SN Remarks System or sub- Composition company and Method Means group country

4. Mode of allowed sale and distribution of the drug: retail/wholesale

5. Whether, prior to the sale and distribution of any drug as referred to in number 3, a certified copy of the document issued by the manufacturer of that drug, guaranteeing that such drug is safe for the people, efficacious and of quality standard, has been submitted or not.

6. Certificate obtainer's: (a) Name and surname: (b) Address: Certificate receiver's: Signature: Date: Certificate issuing officer's: Signature: Name and surname: Designation: Date: Note bene: Any person who sells and distributes the drug pursuant to this certificate shall not be entitled to sell and distribute such drug without submitting to the Department a certified copy of the document which that person has obtained from the manufacturer of the drug guaranteeing that such drug is safe for the people, efficacious and of quality standard. 30 www.lawcommission.gov.np www.lawcommission.gov.np (The matters to be written on the reverse side of this certificate.) Renewal of the certificate Certificate Validity extension Department's Renewing officer's Renewal Remarks period Seal signature and date fees From To 31 www.lawcommission.gov.np www.lawcommission.gov.np Schedule-10 (Relating to Sub-rule (1) of rule 7) Application for license to have publicity and advertisement of drug The Administrator, Department of Drugs Administration. Sir, Whereas, I/we intend to publicize or advertise the following drug; Now, therefore, I/we have made this application, setting out the following matters and affixing a stamp of one rupee hereto, to obtain the license for the same. 1. S Of the drug to be publicized or advertised Remarks N Name System Group Composition Type Active Name of Disease to or sub- or ingredient's manufactur be cured by group kind Name Quantity ing consumption company and country

2. Means of publicity or advertisement of drug: (a) In which language: (b) By which means: (poster, motion picture, newspapers, mobile demonstration etc.)----------- 32 www.lawcommission.gov.np www.lawcommission.gov.np

3. Description relating to the words or symbols to be used for publicity and advertisement of drug:

4. Area where the drug is publicized or advertised: Applicant's: Signature: Name and surname: Address: Date: 33 www.lawcommission.gov.np www.lawcommission.gov.np Schedule-11 (Relating to Sub-rules (2) and (3) of Rule 7) Government of Nepal Ministry of Health Department of Drugs Administration License for publicity and advertisement of drug This license is hereby issued, setting out the following matters, allowing the following person to publicize and advertise the following drug, subject to the Drugs Act, 2035(1978) and the Drugs Registration Rules, 2038(1981). S Of the drug licensed for publication or advertisement Remarks N Name System Group Composition Type Active Name of Disease to or sub- or ingredient's manufactur be cured by group kind Name Quantity ing consumption company and country

2. Allowed for publicity and advertisement of drug: (a) Means: (b) Words or symbols: (c) Area:

3. Licensee’s: (a) Name and surname: (b) Address: (c) Occupation:

4. Fees received for the issuance of license: Rs. 34 www.lawcommission.gov.np www.lawcommission.gov.np

5. Validity period of the license: License receiver’s: Signature: Date: License issuing officer's: Signature: Name and surname: Designation: Date: (The matters to be written on the reverse side of this license.) Renewal of the license Certificate Validity extension Department's Renewing officer's Renewal Remarks period Seal signature and date fees From To 35 www.lawcommission.gov.np www.lawcommission.gov.np Schedule-12 (Relating to Sub-rule (1) of Rule 8) Application for license to conduct clinical trial The Administrator, Department of Drugs Administration. Sir, Whereas, I/we intend to conduct the clinical trial of the following drug; Now, therefore, I/we have made this application, setting out the following matters and affixing a stamp of one rupee hereto, to obtain the license for the same.

1. Of the new drug of which clinical trial is to be conducted: Group Active ingredient's Type or Name System or sub- Composition Remarks kind Name Quantity group

2. Of the disease to be suffered by a patient or person on whom clinical trial is conducted: (a) Name: (b) Method of diagnosis: 36 www.lawcommission.gov.np www.lawcommission.gov.np 3. Of the consumption of the new drug to be administered in the course of clinical trial: (a) Method: (b) Mode: (c) Dosage (daily): (d) Period:

4. Mode of clinical trial:--

5. Place where clinical trial is or intended to be conducted: (a) Name and address of hospital: (b) Name and address of other doctor:

6. Of the person on whom clinical trial is intended to be conducted: (a) Name and surname: (b) Address: (c) Occupation: (d) Qualifications:

7. Mention whether the following details of the new drug are attached or not: (a) Toxicological report: (b) Quality control method: (c) Other necessary matters: Applicant's: Signature: Name and surname: Address: Date: 37 www.lawcommission.gov.np www.lawcommission.gov.np Schedule-13 (Relating to Sub-rule (2) of Rule 8) Government of Nepal Ministry of Health Department of Drugs Administration License for clinical trial This license is hereby issued, setting out the following matters, allowing the following person to conduct clinical trial of the following new drug, subject to the Drugs Act, 2035(1978) and the Drugs Registration Rules, 2038(1981).

1. Of the new drug licensed for clinical trial: Group Active ingredient's Type or Name System or sub- Composition Remarks kind Name Quantity group

2. Of the disease licensed for clinical trial: (a) Name: (b) Method of diagnosis:

3. Of the consumption of the new drug to be administered in the course of clinical trial: (a) Method: (b) Mode: (c) Dosage (daily): (d) Period: 38 www.lawcommission.gov.np www.lawcommission.gov.np

4. Mode of clinical trial:

5. Place where clinical trial is to be conducted:

6. Of the person allowed to conduct clinical trial: (a) Name, surname and address: (b) Occupation: (c) Qualifications:

7. Validity period of license: License receiver’s: Signature: Date: License issuing officer's: Signature: Name and surname: Designation: Date: (The matters to be written on t he reverse side of this license.) Renewal of the license Certificate Department's Validity extension period Renewing officer's Renewal Remarks seal From To signature and date fees 39 www.lawcommission.gov.np www.lawcommission.gov.np Schedule-14 (Relating to Sub-rule (2) of Rule 3, Sub-rule (2) of Rule 4, Sub-rule (2) of Rule 4A, Sub-rule (3) of Rule 4B, Sub-rule (2) of Rule 5, Sub-rule (2) of Rule 6, Sub-rule (2) of Rule 7, Sub-rule (2) of Rule 8, Rule 9, and Sub-rule (2) of Rule 10) Fees Initial fees Renewal SN Description Rs. fees Rs.

1. For the recommendation letter for the establishment of an industry pursuant to Sub-rule (2) of Rule 3. 200/- -

2. For the product license pursuant to Sub-rule (2) of Rule 4 . 200/- 50/-

3. For the sale and distribution registration certificate pursuant to Sub-rule (2) of Rule 4A. 100/- 50/-

4. For the import registration certificate pursuant to Sub-rule (2) of Rule 4B. 200/- 100/-

5. For the export/import recommendation letter pursuant to Sub-rule (2) of Rule 5. 200/- 100/-

6. For the shop registration certificate pursuant to Sub-rule (2) of Rule 5: (a) Capital not exceeding fifty thousand rupees 200/- 100/- (b) Capital from fifty thousand one rupees to one hundred thousand rupees 500/- 250/- (c) Capital from one hundred thousand one rupees to five hundred thousand rupees 1000/- 500/- (d) Capital exceeding five hundred thousand one rupees 2000/- 1000/-

7. For the publicity and advertisement license pursuant to Sub-rule (2) of Rule 7: (a) For the license for publicity and advertisement 5000/- 2500/- 40 www.lawcommission.gov.np www.lawcommission.gov.np Fees Initial fees Renewal SN Description Rs. fees Rs. through television (b) For the license for publicity and advertisement through printing or other media 2000/- 1000/-

8. For the clinical trial license pursuant to Sub-rule (2) of Rule 8. 5000/- -

9. For duplicate copies of license, certificate and recommendation letter pursuant to Sub-rule (2) of Rule 10. (a) For the first time 50/- - (b) For the second time or each time more than that 100/- - 41 www.lawcommission.gov.np